×

Network disruptions

We have been experiencing disruptions on our local network which has affected the stability of these web pages. We have been working with IT support team to get this fixed as a matter of urgency and apologise for any inconvenience.

CATH Classification

Domain Context

CATH Clusters

Superfamily 3.40.50.1460
Functional Family Caspase 2

Enzyme Information

3.4.22.55
Caspase-2.
based on mapping to UniProt P42575
Strict requirement for an Asp residue at P1, with 316-asp being essential for proteolytic activity and has a preferred cleavage sequence of Val- Asp-Val-Ala-Asp-|-.
-!- Caspase-2 is an initiator caspase, as are caspases-8 (EC 3.4.22.61), caspase-9 (EC 3.4.22.62) and caspase-10 (EC 3.4.22.63). -!- Contains a caspase-recruitment domain (CARD) in its N-terminal prodomain, which plays a role in procaspase activation. -!- Two forms of caspase-2 exist that have antagonistic effects: caspase- 2L induces programd cell death and caspase-2S suppresses cell death. -!- Caspase-2 is activated by caspase-3 (EC 3.4.22.56), or by a caspase- 3-like protease. -!- Activation involves cleavage of the N-terminal prodomain, followed by self-proteolysis between the large and small subunits of pro-caspase- 2 and further proteolysis into smaller fragments. -!- Proteolysis occurs at Asp residues and the preferred substrate for this enzyme is a pentapeptide rather than a tetrapeptide. -!- Apart from itself, the enzyme can cleave golgin-16, which is present in the Golgi complex and has a cleavage site that is unique for caspase-2. -!- Alpha-II-spectrin, a component of the membrane cytoskeleton, is a substrate of the large isoform of pro-caspase-2 (caspase-2L) but not of the short isoform (caspase-2S). -!- Belongs to peptidase family C14.

UniProtKB Entries (1)

P42575
CASP2_HUMAN
Homo sapiens
Caspase-2

PDB Structure

PDB 3RJM
External Links
Method X-RAY DIFFRACTION
Organism
Primary Citation
Exploiting differences in caspase-2 and -3 S(2) subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors.
Maillard, M.C., Brookfield, F.A., Courtney, S.M., Eustache, F.M., Gemkow, M.J., Handel, R.K., Johnson, L.C., Johnson, P.D., Kerry, M.A., Krieger, F., Meniconi, M., Munoz-Sanjuan, I., Palfrey, J.J., Park, H., Schaertl, S., Taylor, M.G., Weddell, D., Dominguez, C.
Bioorg.Med.Chem.
CATH-Gene3D is a Global Biodata Core Resource Learn more...